Paper39744893
Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice.
Tian X and 12 others. Aging Cell, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice. Papers, record 39744893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39744893
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| TRPV Cation Channels | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Aging | Major topic |
| Endothelium, Vascular | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Male | |
| Vasodilation | |
| Mesenteric Arteries |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 82100416 | National Natural Science Foundation of China | PubMed | PubMed | ||
| 82200463 | National Natural Science Foundation of China | PubMed | PubMed | ||
| JUSRP123075 | Fundamental Research Funds for the Central Universities | JUSRP123075 | PubMed | NIH RePORTER | |
| GZC20230981 | Postdoctoral Fellowship Program of CPSF | PubMed | PubMed |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34088867 | Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34088867 | PubMed |
| 2 | 27872234 | Downregulation of Endothelial Transient Receptor Potential Vanilloid Type 4 Channel and Small-Conductance of Ca2+-Activated K+ Channels Underpins Impaired Endothelium-Dependent Hyperpolarization in Hypertension. | Hypertension | 2017 | https://conductscience.org/library/papers/27872234 | PubMed |
| 3 | 29626067 | Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure. | Circulation | 2018 | https://conductscience.org/library/papers/29626067 | PubMed |
| 4 | 28899928 | Treatment of hypertension by increasing impaired endothelial TRPV4-KCa2.3 interaction. | EMBO Mol Med | 2017 | https://conductscience.org/library/papers/28899928 | PubMed |
| 5 | 30355078 | Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease. | Circ Res | 2018 | https://conductscience.org/library/papers/30355078 | PubMed |
| 6 | 29109190 | TRPV4 (Transient Receptor Potential Vanilloid 4) Mediates Endothelium-Dependent Contractions in the Aortas of Hypertensive Mice. | Hypertension | 2018 | https://conductscience.org/library/papers/29109190 | PubMed |
| 7 | 33070195 | Omega-3 fatty acids improve flow-induced vasodilation by enhancing TRPV4 in arteries from diet-induced obese mice. | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/33070195 | PubMed |
| 8 | 34616307 | The Transient Receptor Potential Vanilloid 4 Channel and Cardiovascular Disease Risk Factors. | Front Physiol | 2021 | https://conductscience.org/library/papers/34616307 | PubMed |
| 9 | 24250251 | The vascular endothelium and human diseases. | Int J Biol Sci | 2013 | https://conductscience.org/library/papers/24250251 | PubMed |
| 10 | 32402646 | Endothelial TRPV4 channels and vasodilator reactivity. | Curr Top Membr | 2020 | https://conductscience.org/library/papers/32402646 | PubMed |
| 11 | 34275335 | Novel Role of GPR35 (G-Protein-Coupled Receptor 35) in the Regulation of Endothelial Cell Function and Blood Pressure. | Hypertension | 2021 | https://conductscience.org/library/papers/34275335 | PubMed |
| 12 | 32008372 | Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity. | Circulation | 2020 | https://conductscience.org/library/papers/32008372 | PubMed |
| 13 | 15820197 | Endothelial aging. | Cardiovasc Res | 2005 | https://conductscience.org/library/papers/15820197 | PubMed |
| 14 | 21339899 | The endothelium and its role in regulating vascular tone. | Open Cardiovasc Med J | 2010 | https://conductscience.org/library/papers/21339899 | PubMed |
| 15 | 26947561 | Increasing TRPV4 expression restores flow-induced dilation impaired in mesenteric arteries with aging. | Sci Rep | 2016 | https://conductscience.org/library/papers/26947561 | PubMed |
| 16 | 26388427 | TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation. | Sci Rep | 2015 | https://conductscience.org/library/papers/26388427 | PubMed |
| 17 | 30043283 | Disruption of GPR35 Exacerbates Dextran Sulfate Sodium-Induced Colitis in Mice. | Dig Dis Sci | 2018 | https://conductscience.org/library/papers/30043283 | PubMed |
| 18 | 29860395 | The Orphan Receptor GPR35 Contributes to Angiotensin II-Induced Hypertension and Cardiac Dysfunction in Mice. | Am J Hypertens | 2018 | https://conductscience.org/library/papers/29860395 | PubMed |
| 19 | 22556255 | Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. | Science | 2012 | https://conductscience.org/library/papers/22556255 | PubMed |
| 20 | 33882682 | Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. | Circulation | 2021 | https://conductscience.org/library/papers/33882682 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42422948 | Angiogenesis in Lung Regeneration and Aging. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/42422948 | PubMed |
| 42123594 | The Ca2+-NO-ROS Crosstalk Induced by Arachidonic Acid in Human Lung Fibroblasts: Implications for Pulmonary Fibrosis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123594 | PubMed |
| 40443656 | The NLRP3 inflammasome: a therapeutic target of phytochemicals in treating atherosclerosis (a systematic review). | Front Immunol | 2025 | https://conductscience.org/library/papers/40443656 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLT1 | 2321 | PubTator's text mining | https://conductscience.org/library/genes/2321 | NCBI Gene |
| GPR35 | 2859 | PubTator's text mining | https://conductscience.org/library/genes/2859 | NCBI Gene |
| TRPV4 | 59341 | PubTator's text mining | https://conductscience.org/library/genes/59341 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39744893
GET https://conductscience.org/api/papers/v1/39744893/references?page=2